Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFAlin-Modified Peptidic Radioligands Targeting Both Integrin α(v)β(3) and the MC1 Receptor—Suitable for the Specific Visualization of Melanomas?

Samankaltaisia teoksia

• Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
  Tekijä: Judmann, Benedikt, et al.
  Julkaistu: (2020)
• Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y1)- and GRP-Receptors—An Improvement for Breast Cancer Imaging?
  Tekijä: Alicia Vall-Sagarra, et al.
  Julkaistu: (2018-07-01)
• Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y(1))- and GRP-Receptors—An Improvement for Breast Cancer Imaging?
  Tekijä: Vall-Sagarra, Alicia, et al.
  Julkaistu: (2018)
• Hybrid Multimodal Imaging Synthons for Chemoselective and Efficient Biomolecule Modification with Chelator and Near-Infrared Fluorescent Cyanine Dye
  Tekijä: Hübner, Ralph, et al.
  Julkaistu: (2020)
• Identification of a Suitable Peptidic Molecular Platform for the Development of NPY(Y(1))R‐Specific Imaging Agents
  Tekijä: Krieger, Korbinian, et al.
  Julkaistu: (2020)